A focus on risk factor management

Criqui MH , Fronek A , Barrett-Connor E , Klauber MR , Gabriel S , Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-515.

Fowkes FG , Housley E , Cawood EH , Macintyre CC , Ruckley CV , Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392.

Klevsgard R , Hallberg IR , Risberg B , Thomsen MB. Quality of life associated with varying degrees of chronic lower limb ischaemia: comparison with a healthy sample. Eur J Vasc Endovasc Surg 1999; 17: 319-325.

Regensteiner JG , Ware JE Jr , McCarthy WJ et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002; 50: 1939-1946.

Zheng ZJ , Sharrett AR , Chambless LE et al. Associations of ankle brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 115-125.

Kornitzer M , Dramaix M , Sobolski J , Degre S , De Backer G. Ankle=arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995; 46: 211-219.

Hirsch AT , Gloviczki P , Drooz A , Lovell M , Creager MA. The mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. Vasc Med 2004; 9: 78-86.

Scottish Intercollegiate Guidelines(SIGN) . Diagnosis and management of peripheral arterial disease. http:==www.sign.ac.uk=events=pvd.html

Belch JJ , Topol EJ , Agnelli G et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 884-892.

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-1621.

Hirsch AT , Criqui MH , Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.

Management of peripheral arterial disease (PAD) . TransAtlantic Inter-Society Consensus (TASC). Int Angiol 2000; 19: I-XXIV, 1-304.

McDermott MM , Mehta S , Ahn H , Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12: 209-215.

Clark AL , Byrne JC , Nasser A , McGroarty E , Kennedy JA. Cholesterol in peripheral vascular disease a suitable case for treatment? QJM 1999; 92: 219-222.